|
| View:
Latest News | Top Stories |
|
| 1.
|
Dyax shares rocket on FDA clearance for Kalbitor
-
AP
-
2 hours, 42 minutes ago
Shares of Dyax Corp. jumped to their highest price in more than a year on Wednesday after regulators approved marketing of the company's hereditary angioedema drug Kalbitor.
|
|
| 2.
|
CytRx Corporation (NASDAQ: CYTR) Looking More Like a Solid Rebound Play
-
Marketwire
-
Wed 11:05 am ET
|
|
| 3.
|
Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial
-
PR Newswire
-
Wed 9:30 am ET
Peregrine Pharmaceuticals, Inc. today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with relapsed glioblastoma multiforme , the deadliest form of brain cancer.
|
|
| 4.
|
Hemispherx Biopharma Announces Investor Conference Call
-
GlobeNewswire
-
Wed 8:30 am ET
PHILADELPHIA -- Hemispherx Biopharma, Inc. announces an investor update by teleconference on Thursday, December 3, 2009 at 10:00am EST. The update will cover regulatory status of its platform technology (Ampligen, Alferon-N, Alferon LDO), strategic partnering and other matters, followed by a Q and A period.
|
|
| 5.
|
PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share
-
PR Newswire
-
Wed 8:30 am ET
PDL BioPharma, Inc. today announced that it has established the per share amount of the previously announced $200 million special dividend as $1.67 per share. The dividend will be paid on December 15, 2009 to all holders of the Company's stock as of the December 1, 2009 record date.
|
|
| 6.
|
Novavax swine flu vaccine meets study goal
-
AP
-
Wed 8:27 am ET
Novavax Inc. said Wednesday that the swine flu vaccine it's developing prompted an immune system response in patients during a midstage study being conducted in Mexico.
|
|
| 7.
|
Genta to Support Initiation of New Clinical Trial using Ganite® as Treatment for Life-Threatening Infections in Patients with Cystic Fibrosis
-
Business Wire
-
Wed 8:02 am ET
BERKELEY HEIGHTS, N.J.----Genta Incorporated announced that the Company will supply Ganite® for a new clinical trial that will be initiated in patients with cystic fibrosis who may develop serious infections.
|
|
| 8.
|
Hemispherx Biopharma Receives Complete Response Letter From FDA on Ampligen(R) New Drug Application for Chronic Fatigue Syndrome
-
GlobeNewswire
-
Tue 4:30 pm ET
PHILADELPHIA -- Hemispherx Biopharma, Inc. , announced that it received a Complete Response Letter from the U.S. Food and Drug Administration which describes specific additional recommendations related to the Ampligen NDA.
|
|
| 9.
|
Emerging Stock Report Initiates Independent Research Coverage On ADVENTRX Pharmaceuticals, Inc.
-
GlobeNewswire
-
Tue 11:19 am ET
CALGARY, Alberta -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on ADVENTRX Pharmaceuticals, Inc. . Emerging Stock Report is currently offering a complimentary trial subscription to the investment community.
|
|
| 10.
|
CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine
-
PR Newswire
-
Tue 10:15 am ET
CEL-SCI Corporation , a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today that it has retained the services of an international Contract Research Organization to run CEL-SCI's upcoming Phase III clinical trial in advanced primary head and neck cancer with the Company's lead product candidate, Multikine®.
|
|
